Yang Hua, Hu Zhongyi, Sha Wei, Lu Junmei, Cui Zhenling, Wang Jie, Huang Xiaochen, Xiao Heping
Shanghai Key Laboratory of Tuberculosis, Diagnosis and Treat Centre of Tuberculosis, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai 200433, China.
Email:
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 Apr;48(4):318-23.
To induce Mycobacterium tuberculosis (MTB) resistance with ofloxacin (Ofx) of stepwise increasing concentration in vitro, investigate stability to fluoroquinolone (FQs) antibiotic of MTB, and analyze the molecular mechanism and mutation specialty of drug resistance preliminarily.
MTB Standard strain H37RV and 24 clinical isolates susceptible to Ofx were selected and experimentally serially subcultured in liquid culture medium containing increasing concentration of Ofx and induced the drug resistance to Ofx. Variety of Minimal Inhibitory Concentrations (MICs) to FQs drugs were detected by microwell-MIC-test method. Mutations of quinolone resistance determining region (QRDR) of gyrA gene were sequenced and identified. Relationship of different mutation sites and drug resistant degree were analyzed. A total of 6 MTB clinical isolates resistant to Ofx and induced drug resistant isolates in vitro were serially subcultured in liquid culture medium without drug. Variety of drug resistant stability, including MIC and mutation of gyrA gene were detected.
MIC values of 21 Ofx susceptible isolates after induction were eight times higher than before, which were induced to drug resistant strains successfully and also resistant to Lfx and Mfx. Hot mutations of QRDR of gyrA gene were detected by sequencing, except one strain. Mutation of codon 94 occurred in 60% (12/20) of the strains with mutations and corresponding value of 50% Minimal Inhibitory Concentrations(MIC50) was ≥ 8 µg/ml. In all, 4 of 6 MTB clinical isolates resistant to Ofx harbored mutation of codon 90 (67%) , but the corresponding value of MIC50 was 2 µg/ml. After 21 serially subcultured in liquid culture medium without drug, MIC values of 6 clinical isolates resistant to Ofx were not changed obviously and mutations were also not changed. After 11 times serially subcultured in culture medium without drug, MIC values of induced drug resistant strains were also not changed obviously, but new mutations were detected in QRDR of 3 isolates.
MTB strains resistant to three kinds of FQs antibiotic were obtained by induction in vitro with Ofx. Codons 88, 94 mutations of QRDR of gyrA gene were related to the high level FQs drug resistance of MTB. Drug resistant stability of MTB to FQs was strong, and it is difficult for MTB to resume susceptibility.
在体外以浓度逐步递增的氧氟沙星(Ofx)诱导结核分枝杆菌(MTB)耐药,研究MTB对氟喹诺酮类(FQs)抗生素的稳定性,并初步分析耐药的分子机制及突变特点。
选取MTB标准菌株H37RV及24株对Ofx敏感的临床分离株,在含浓度递增的Ofx的液体培养基中进行实验性连续传代,诱导其对Ofx产生耐药。采用微孔板-微量肉汤稀释法检测对FQs药物的多种最低抑菌浓度(MICs)。对gyrA基因喹诺酮耐药决定区(QRDR)进行测序鉴定。分析不同突变位点与耐药程度的关系。将6株对Ofx耐药的MTB临床分离株及体外诱导耐药株在无药的液体培养基中连续传代。检测包括MIC及gyrA基因突变在内的多种耐药稳定性。
21株Ofx敏感株诱导后MIC值比诱导前高8倍,成功诱导为耐药菌株,且对左氧氟沙星(Lfx)和莫西沙星(Mfx)也耐药。测序检测到gyrA基因QRDR的热点突变,除1株外。60%(12/20)发生突变的菌株出现密码子94突变,50%最低抑菌浓度(MIC50)值≥8μg/ml。6株对Ofx耐药的MTB临床分离株中,4株(67%)存在密码子90突变,但MIC50值为2μg/ml。21株在无药液体培养基中连续传代后,6株对Ofx耐药的临床分离株MIC值无明显变化,突变也未改变。在无药培养基中连续传代11次后,诱导耐药株MIC值也无明显变化,但3株分离株的QRDR检测到新的突变。
通过Ofx体外诱导获得了对3种FQs抗生素耐药的MTB菌株。gyrA基因QRDR的密码子88、94突变与MTB对FQs的高水平耐药有关。MTB对FQs的耐药稳定性强,恢复敏感性困难。